close
Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com.
The European Commission has authorized GSK’s HIV-focused unit ViiV Healthcare’s cabotegravir long-acting injectable and tablets, the British drugmaker said on Tuesday.
EUROPEAN COMMISSION CHIEF URSULA VON DER LEYEN ASSURES AID TO FLOOD-STRICKEN SLOVENIA DURING VISIT
Cabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acquired HIV-1 infection in high-risk adults and adolescents weighing at least 77.16 pounds, according to the company.
The GlaxoSmithKline logo is seen in this illustration, Aug. 10, 2022. (REUTERS/Dado Ruvic/Illustration/File Photo)
Sold under brand name Apretude, it is currently approved for use in the United States, Australia, Zimbabwe, South Africa, Malawi, Botswana and Brazil.
CLICK HERE TO GET THE FOX NEWS APP
close Video NYC official says 'party is over' for illegal immigrants New York City council…
Robert F. Kennedy Jr., Tulsi Gabbard and Kash Patel testified before Senate committees on Capitol…
President Donald Trump's choice to head the Department of Veterans Affairs, Doug Collins, passed a…
President Trump’s FBI director nominee Kash Patel pledged in his confirmation to end the "targeting"…
The Senate has confirmed President Donald Trump’s pick to lead the Interior Department, former North…
The top Republican on the Senate's chief health committee, Sen. Bill Cassidy, R-La., indicated Thursday…